CBD topicals – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Tue, 13 Dec 2022 18:57:38 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.4 Branded Legacy, Inc. Sells Magic 1 Promotions, LLC For $1 Million https://mjshareholders.com/branded-legacy-inc-sells-magic-1-promotions-llc-for-1-million/ Tue, 13 Dec 2022 18:57:38 +0000 https://www.cannabisfn.com/?p=2971744

Ryan Allway

December 13th, 2022

News, Top News


Strategic Management & Opportunity Corp (OTC: SMPP) Purchases Magic 1 Promotions

Orlando, FL, Dec. 13, 2022 (GLOBE NEWSWIRE) — Orlando, FL — December 13, 2022 — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce it has sold Magic 1 Promotions, LLC to Strategic Management & Opportunity Corp (OTC: SMPP). Strategic Management & Opportunity acquired all the membership interest in Magic 1 Promotions, LLC in exchange for One Million ($1,000,000), to be paid in a combination of One Hundred Million (100,000,000) restricted common shares of Strategic Management & Opportunity Corp. (OTC: SMPP) and cash.

Brandon Spikes, chairman of Branded Legacy, Inc., stated, “We are really excited about this transaction and the additional value it brings to our shareholders. We recently did a similar transaction with another public company and have seen a very positive response. By strategically spinning off assets that are not our primary focus, we are able to grow the business successfully for the benefit of our shareholders and allow our shareholders to be vested in multiple companies.”

Spikes Continued “Following the transaction we plan to issue our shareholders a dividend from the shares of the purchasing company used to purchase Magic 1 Promotions. Furthermore, this may help Magic 1 Promotions obtain the funding necessary for its projected growth. We are currently working with our SEC attorney on one dividend and will be engaging our attorney for this dividend as well. Will release updates as we have them.”

In a previous news release, the company announced the acquisition of ReelSkinz. ReelSkinz is more than just a lifestyle brand; it is a company that combines practicality, protection, and fashion into the ultimate ocean and outdoor apparel.

Spikes concluded, “We have been in communication with our transfer agent in regard to updating the authorized shares. We have been assured during their monthly update to OTC Markets, that the transfer agent will be updating the authorized shares to six hundred million (600,000,000).”

About Spikes CBDX: Spikes CBDX is a line of CBD products designed to assist athletes perform better and recover faster. The Company believes that post workout recovery, with Spikes CBDX products, can lower inflammation, aid in making your body stronger, and help recover from injuries naturally. The CBD line also targets individuals who are looking for pain relief, better sleep, faster recovery and lowering inflammation. Spikes CBDX provides tinctures, lotions, moisturizer, and cryo-gel roll-ons. To view all the Spikes CBDX products please visit: spikescbdx.com.

About Versatile Industries: Versatile Industries, LLC is an acquisition company used to incubate companies to eventually spin off into their own public vehicles. Currently owns patent for a sports training assembly called The Quickness, a solar and water treatment company Magic 1 Promotions h2oandsolarsolutions.com, LLC and Astound NMN. By supplementing NMN it helps maintain NAD+ levels, ultimately slowing the effects of aging. www.astoundnmn.com

Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company’s control.

www.brandedlegacy.com
(407) 337-0642
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs https://mjshareholders.com/dr-annarx-announces-rob-simbowe-cbd-muscle-and-joint-rubs/ Wed, 30 Mar 2022 16:42:35 +0000 https://www.cannabisfn.com/?p=2942329

Ryan Allway

March 30th, 2022

News, Top News


CAPE TOWN, SA / ACCESSWIRE / March 30, 2022 / WUHAN GENERAL GROUP, INC. (WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update:

Dr. AnnaRx™ is pleased to announce the launch of its new line of CBD Muscle and Joint Rubs endorsed and promoted by MMA Pro Fighter Rob “The Black Tiger” Simbowe.

The initial line will consist of 3 variants:

1. CBD Pain-Relief Extra Strength Muscle Rub – 1200 mg

A deep penetrating, dual-action, medicated broad-spectrum CBD rub that is specially formulated to quickly absorb through the skin and muscle to provide pain relief from muscle and joint-related injuries, strains, and sprains. On contact, it provides deep cooling relief, then activates to heat for deep-penetrating, long-lasting pain alleviation.

2. CBD Warming Pre-Workout Muscle Rub – 600 mg

A medicated broad-spectrum CBD pre-workout muscle rub clinically designed to warm and prepare your muscles before your workout, helps protect against muscle and joint-related injuries, strains, and sprains.

3. CBD Cooling Post-Workout Muscle Rub – 600 mg

A medicated broad-spectrum CBD post-workout muscle rub clinically designed to soothe and cool your muscles post-workout, helps protect against muscle and joint-related injuries, strains, and sprains.

The muscle rubs are a new and exciting addition with strong brand differentiators in the category. They will be available in select major pharmacies and health store chains in South Africa first, then Zambia – Rob’s country of birth and upbringing.

“Having Rob represent the Dr. AnnaRx™ brand is a real honor for us. He has an incredible life story that is so inspiring. His deep knowledge of health, fitness, nutrition, and life skills is remarkable. He’s a true role model for the youth and anyone who aspires to do great things. We are also very excited to serve our consumers with these extraordinary three CBD products. The muscle rubs are made using the highest quality CBD from Colorado, USA, African medicinal ingredients and formulated for maximum results.” – Dr. Anna Morera Leralta – Chief Medical Officer, M2Bio Sciences.

Rob Simbowe, Director of Health and Fitness and Brand Ambassador, M2Bio Sciences added: “The meaning of life is not simply to exist, to survive, but to move ahead, to go up, to achieve, to conquer. The meaning of life differs from man to man, from day to day, and from hour to hour, and that’s why I fight not just in the ring but outside in life too – to be the best version of myself I can possibly be. I use CBD as part of my daily regimen to not let any pain stand in my way – it helps me train harder and be the best version of myself when training and competing.”

ROB SIMBOWE UPCOMING FIGHT:

Simbowe vs Dogodo
Date: 09, April 2022
Venue: EFC Performance Institute, Johannesburg, South Africa
Find out more here

IMMAF Africa Championships

Rob has recently been selected as part of the coaching staff for the IMMAF Africa Championships, his grass route connection and popularity within the Zambian sporting community allow for the perfect platform launch into the country:

MMA Zambia is the governing body for Mixed Martial Arts in Zambia, mandated by the National Sports Council of Zambia to regulate the sport in the country.

We are proud to have Rob Simbowe on the MMA Zambia board. Rob is a pioneer of the sport here; he is Zambia’s first-ever Pro MMA athlete and EFC fighter. Due to his wealth of experience, he has been selected to be part of the MMA Zambia coaching staff for the IMMAF Africa Championships taking place at the EFC Performance Institute in Johannesburg from the 28th to the 30th of April 2022.

The Dr. AnnaRx™ CBD muscle relief line endorsed by Rob is a fantastic product for athletes and recreational fitness enthusiasts alike. You can be assured that with Rob’s name associated with the brand, like Rob, it does everything it says it does and more. We look forward to our athletes using it as a strong and effective aid for recovery after training and competition,” says Benjamin Bush – MD – Ulemu Fight Academy, President – MMA Zambia.

About Wuhan General Group, Inc./ M2Bio Sciences, Inc

Wuhan General Group, Inc. (DBA M2bio Sciences), through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.

Publicly traded company (OTC Pink:WUHN)

Visit Website
Contact via E-mail
Follow us on Twitter
Follow us on Facebook
Follow us on YouTube
Follow us on Instagram

Forward-Looking Statements:

Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: Wuhan General Group, Inc./M2Bio Sciences, Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>